Efficacy of panitumumab plus FOLFI-RI versus FOLFIRI alone in patients with wild-type (wt) KRas metastatic colorectal cancer (mCRC) treated with prior oxaliplatin or bevacizumab regimes: Results from 20050181. ECCO16-ES-MO36-ESTRO30 Abstracts Nr. 6132. - Price, TJ (EJC, 2011)
et al.